Sponsored Links
| Study Evaluating SIR-Spheres(R) Microspheres In Patients With Metastatic Breast Cancer Presented At The 2011 ASCO Annual Meeting |
 |
 |
 |
| Medical News - Breast Cancer | |||
|
Sirtex, a leading developer and manufacturer of targeted, innovative liver cancer therapies, today announced the results of a five-year study evaluating the tolerability, efficacy and survival rates of Selective Internal Radiation Therapy (SIRT), also known as radioembolization, using SIR-Spheres® microspheres in patients with liver metastases from breast cancer that are re... Read more: Breast Cancer News From Medical News Today
|